The Anti-NMDA Receptor Encephalitis Foundation Inc.
Charitable organization · Ottawa, Ontario · BN 843328337RR0001 · Core Health Care · website
Source: T3010 return, FPE 2022-12-31. Split of total expenditures ($3,531) as filed with the CRA.
The Anti-NMDA Receptor Encephalitis Foundation Inc. is a charitable organization based in Ottawa, Ontario, classified by the CRA under core health care. In its fiscal year ending December 31, 2022, it reported $5,309 in revenue and $3,531 in expenditures.
In 2024, 2 other registered charities reported granting it a combined $172.
Compared with 1,832 health charities of similar size, its share of spending on mission — charitable programs plus grants to other charities — ranked above 37% of peers.
Its filed list of directors and trustees shows 5 names.
In its own words
Raise awareness of the disease through education promote clinical and basic science researh concerning the risk factors and disease pathogenises promote diagnosis and treatment of the disease provide an ongoing forum for patients and their caregivers provide a clearninghouse of published information for the professional caregivers and patients through our weekly newslettermaintain and manage a partner physicians network that identifies physicians with experience and expertise in the field of diagnosing treating and managing patients in canada and around the world.
Ongoing-program description from its T3010 filing, verbatim.
The ledger, 2020–2022
| Year | Revenue | Spending | Programs | Fundraising | Gifts out | Net assets |
|---|---|---|---|---|---|---|
| 2022 | $5,309 | $3,531 | $2,683 | — | — | $22K |
| 2021 | $5,430 | $4,936 | $4,186 | — | — | $21K |
| 2020 | $7,639 | — | — | — | — | $8,600 |
Revenue printed in red where the year ran a deficit. Fiscal years by period end.
Money between charities, 2024
Received $172 from 2 charities:
As reported on the donors’ own T3010 qualified-donee schedules.
Directors & trustees (2022)
Gregory Day (clinical director); Kelly McNagny (director); Harry Peery (director); Nesrin Shaheen (president); Valdez Yanet (director).
As listed on its 2022 return.
Check the source
Every figure on this page is from The Anti-NMDA Receptor Encephalitis Foundation Inc.’s own T3010 filings, published by the Canada Revenue Agency. Verify against the CRA’s charities listing (search BN 843328337RR0001), or read how we compute the receipt.